Related Experiment Video
Updated: Jan 12, 2026

10:37
Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
22.9K
Proteomic perspectives on platelet reactivity: towards precision thrombosis research
Joseph E Aslan1,2,3
1Department of Biomedical Engineering.
Current Opinion in Hematology
|November 4, 2025
Summary
Platelet proteomics reveals how protein changes impact blood clotting and inflammation across life stages and diseases. These findings offer new biomarkers and therapeutic targets for precision medicine in thrombotic disorders.
Area of Science:
- Biochemistry
- Molecular Biology
- Vascular Biology
Background:
- Platelet protein systems are crucial for hemostasis, thrombosis, and inflammation.
- Clinical application of platelet proteomics research is currently limited.
- Understanding platelet function requires advanced proteomic analysis.
Purpose of the Study:
- To review recent advancements in platelet proteome research.
- To highlight the role of platelet proteomics in development, aging, and disease.
- To explore the clinical translation of platelet proteomics findings.
Main Methods:
- Review of recent studies on platelet proteomes and function.
- Analysis of phosphoproteomics data for signaling pathways.
- Examination of platelet secretomes, extracellular vesicles, and thrombus proteomic profiles.
Main Results:
- Defined platelet proteomes associated with hypoactivity and hyperactivity across developmental and aging states.
- Identified signaling pathways linked to platelet dysregulation in aging, nutrient states, and diseases via phosphoproteomics.
- Uncovered disease-associated signatures in diabetes, neurodegeneration, cancer, and myeloproliferative neoplasms from secretome and extracellular vesicle analyses.
- Revealed distinct platelet signatures in thrombi from myocardial infarction, stroke, and sepsis, implicating roles in clot architecture, fibrinolysis resistance, and immune crosstalk.
Conclusions:
- Platelet proteomics defines alterations in platelet composition due to development, aging, and disease.
- Identified molecular effectors of platelet function, biomarkers, and therapeutic targets.
- Platelet proteomics is poised to advance precision strategies for thrombotic and inflammatory disorders and refine vascular biology models.
Related Concept Videos
Structure and Function of Platelets
2.9K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
2.9K
Formation of the Platelet Plug
8.6K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.6K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.1K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.1K

